Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

NCT00028327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
DRUG: Nelfinavir mesylate
DRUG: Efavirenz
DRUG: Lamivudine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)